This site is intended for health professionals only

Covid-19 Primary Care Resources


ADHD medications during the COVID-19 outbreak



Expert guidance encourages flexibility around monitoring to enable continued access to ADHD medications

This information is sourced from the European ADHD Guidelines Group:

  • The inability to do routine, face-to-face clinical visits to initiate and monitor medication should not be viewed as an absolute contraindication to pharmacotherapy
  • Parents of children with ADHD and adolescents or adults with ADHD should avoid increasing doses or adding doses to manage a crisis or stress related to confinement
  • Use of antipsychotic medications to manage disruptive behaviour or the use of sedatives when not clinically indicated should be avoided
  • There is no strong rationale to introduce weekend drug holidays during the current crisis
  • Routine cardiovascular clinical examination and face-to-face monitoring for individuals with ADHD without any cardiovascular risk factors could be postponed
  • If possible, monitoring of blood pressure and heart rate using home blood pressure machines is recommended
  • Routinely recommend parent-focused ADHD interventions, as well as mental-wellbeing interventions for children and young people.